Semler Scientific Inc (SMLR)
Official siteMEDICAL DEVICES
Last updated: Jan 16, 2026 at 4:00 PM ET
Semler Scientific Inc (SMLR) Financials: Revenue, Profit and Cash Flow
Semler Scientific reported revenue of $56.29M for the fiscal year ended Dec 31, 2024, down 17.4% from the year before. That year, net income was $40.90M with a net margin of 72.7%, operating cash flow was $24.41M and free cash flow was $24.36M. The quarter ended Sep 30, 2025 had revenue of $7.49M and net income of $16.90M.
Revenue and Margins
The operating margin was 37.2% in the fiscal year ended Dec 2024. Over the 9 years to Dec 2024, revenue grew from $7.00M, a compound annual rate of 26.1%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2024 | $56.29M | -17.4% | 91.5% | 37.2% | 72.7% |
| Dec 2023 | $68.18M | +20.3% | 89.8% | 32.6% | 30.2% |
| Dec 2022 | $56.69M | +6.9% | 92.5% | 30.3% | 25.3% |
| Dec 2021 | $53.03M | +37.4% | 88.5% | 36.7% | 32.5% |
| Dec 2020 | $38.60M | +17.8% | 91.3% | 41.3% | 36.3% |
| Dec 2019 | $32.77M | +52.5% | 88.8% | 32.7% | 46.0% |
| Dec 2018 | $21.49M | +72.6% | 87.4% | 24.9% | 23.3% |
| Dec 2017 | $12.45M | +67.5% | 79.5% | -6.9% | -12.1% |
| Dec 2016 | $7.43M | +6.2% | 63.2% | -29.0% | -34.4% |
| Dec 2015 | $7.00M | N/A | 38.8% | -120.3% | -121.4% |
Income Statement
In the fiscal year ended Dec 2024, net income rose 98.7% from the year before. In the quarter ended Sep 2025, net income rose 201.2% from the same quarter a year earlier.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $56.29M | $68.18M | $56.69M | $53.03M | $38.60M | $32.77M | $21.49M | $12.45M | $7.43M | $7.00M |
| Cost of revenue | $4.76M | $6.98M | $4.25M | $6.12M | $3.36M | $3.66M | $2.70M | $2.55M | $2.74M | $4.28M |
| Gross profit | $51.53M | $61.20M | $52.43M | $46.91M | $35.25M | $29.11M | $18.79M | $9.90M | $4.70M | $2.72M |
| Research and development | $4.79M | $5.77M | $4.81M | $3.78M | $2.94M | $2.48M | $2.08M | $1.83M | $0 | $0 |
| Operating income | $20.93M | $22.26M | $17.20M | $19.45M | $15.96M | $10.71M | $5.34M | -$853.00K | -$2.16M | -$8.42M |
| Net income | $40.90M | $20.58M | $14.32M | $17.22M | $14.01M | $15.08M | $5.01M | -$1.51M | -$2.55M | -$8.50M |
| EBITDA | $46.59M | N/A | $17.79M | $20.07M | $17.04M | $11.33M | $5.86M | -$143.00K | -$1.53M | -$8.04M |
Quarterly
| Line item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $7.49M | $8.22M | $8.84M | $12.41M | $13.51M | $14.46M | $15.90M | $15.06M | $16.32M | $18.61M | $18.21M | $13.79M |
| Gross profit | $6.86M | $7.48M | $7.90M | $11.31M | $12.36M | $13.21M | $14.66M | $11.67M | $15.21M | $17.39M | $16.94M | $12.61M |
| Operating income | -$5.39M | -$2.05M | -$31.10M | $3.54M | $5.07M | $5.35M | $6.98M | $2.52M | $6.30M | $7.18M | $6.26M | $3.62M |
| Net income | $16.90M | $66.93M | -$64.70M | $29.21M | $5.61M | $11.00K | $6.07M | $4.22M | $5.51M | $5.88M | $4.97M | $3.22M |
Balance Sheet
As of Dec 2024, the balance sheet showed $8.82M in cash and equivalents and no debt.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $239.83M | $78.06M | $62.69M | $50.67M | $34.64M | $18.29M | $7.72M | $4.24M | $3.07M | $3.08M |
| Current assets | $22.69M | $65.94M | $48.91M | $45.54M | $26.60M | $11.44M | $6.24M | $2.88M | $1.59M | $1.75M |
| Cash and equivalents | $8.82M | $57.20M | $23.01M | $37.32M | $22.08M | $7.74M | $3.28M | $1.46M | $622.00K | $405.00K |
| Total liabilities | $9.08M | $6.27M | $7.02M | $5.13M | $4.85M | $5.21M | $3.52M | $6.82M | $5.99M | $4.15M |
| Short-term debt | $0 | $90.00K | $85.00K | $80.00K | $2.80M | N/A | N/A | $1.02M | $81.00K | N/A |
| Long-term debt | $0 | N/A | N/A | N/A | N/A | N/A | $11.00K | $26.00K | $938.00K | N/A |
| Shareholder equity | $230.75M | $71.80M | $55.68M | $45.55M | $29.79M | $13.07M | $4.20M | -$2.58M | -$2.92M | -$1.07M |
Quarterly
| Line item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $596.68M | $522.60M | $293.44M | $239.83M | $92.19M | $84.79M | $83.86M | $78.06M | $79.44M | $75.46M | $70.26M | $62.69M |
| Total liabilities | $136.93M | $139.19M | $131.76M | $9.08M | $6.84M | $6.39M | $5.95M | $6.27M | $8.67M | $10.20M | $9.06M | $7.02M |
| Cash and equivalents | $10.18M | $13.48M | $9.74M | $8.82M | $6.57M | $7.33M | $62.75M | $57.20M | $37.50M | $39.49M | $5.30M | $23.01M |
| Shareholder equity | $459.75M | $383.41M | $161.68M | $230.75M | $85.36M | $78.40M | $77.91M | $71.80M | $70.77M | $65.26M | $61.20M | $55.68M |
Cash Flow
In the fiscal year ended Dec 2024, free cash flow was 99.8% of operating cash flow. Share repurchases came to 12.3% of it.
Annual
| Line item | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $24.41M | $21.33M | $17.46M | $16.06M | $15.11M | $12.73M | $4.70M | $621.00K | -$1.80M | -$4.13M |
| Capital expenditures | $51.00K | $345.00K | $2.16M | $825.00K | $758.00K | $1.70M | $844.00K | $971.00K | $814.00K | $1.10M |
| Free cash flow | $24.36M | $20.98M | $15.30M | $15.23M | $14.36M | $11.03M | $3.85M | -$350.00K | -$2.62M | -$5.24M |
| Share repurchases | $3.00M | $1.95M | $4.99M | $0 | N/A | $6.63M | N/A | N/A | N/A | N/A |
| Investing cash flow | -$189.98M | $18.40M | -$26.84M | -$825.00K | -$1.01M | -$1.70M | -$843.00K | -$968.00K | -$814.00K | $996.00K |
| Financing cash flow | $117.19M | -$5.41M | -$4.94M | $13.00K | $230.00K | -$6.57M | -$2.03M | $1.18M | $2.83M | -$612.00K |
Quarterly
| Line item | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$32.95M | $514.00K | -$1.91M | $7.43M | $6.42M | $4.93M | $5.62M | $4.44M | $4.83M | $11.20M | $861.00K | $1.71M |
| Capital expenditures | $11.00K | $149.67M | $0 | $32.00K | $8.44M | $44.00K | $4.00K | $738.00K | $149.00K | $295.00K | $639.00K | $811.00K |
| Free cash flow | -$32.96M | -$149.15M | -$1.91M | $7.39M | -$2.01M | $4.89M | $5.62M | $3.70M | $4.68M | $10.90M | $222.00K | $899.00K |
Frequently Asked Questions About SMLR
What is Semler Scientific's annual revenue?
Semler Scientific reported revenue of $56.29M for the fiscal year ended Dec 31, 2024.
How fast is Semler Scientific's revenue growing?
Revenue was down 17.4% for the fiscal year ended Dec 31, 2024 compared with the year before. The compound annual revenue growth rate over 3 years was 2.0%.
Is Semler Scientific profitable?
Yes. Semler Scientific reported net income of $40.90M for the fiscal year ended Dec 31, 2024, with a net margin of 72.7%.
How much free cash flow does SMLR generate?
For the fiscal year ended Dec 31, 2024, operating cash flow of $24.41M minus capital expenditures of $51.00K produced free cash flow of $24.36M.
How much debt does Semler Scientific have?
The balance sheet dated Dec 31, 2024 reported long-term debt of $0, short-term debt of $0 and cash and equivalents of $8.82M.
SMLR pages: Overview, Financials